Mytos

Mytos, founded in 2018, is building a fully automated cell manufacturing platform for biotechnology that can completely automate the complex and critical processes of human cell production, a crucial part of the drug development process. A key bottleneck in biotechnology is the manual production of human cells, which slows down the development of each new drug. Whether in large pharmaceutical companies or early startups, scientists lack a viable solution to address the laborious process of manually culturing human cells — a task that consumes valuable time daily and delays the speed of drug development.